SNDX SYNDAX PHARMACEUTICALS INC
2026Q1 · CUSIP 87164F105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
244
Δ holders QoQ
+14
Breadth percentile
Top 22%
Whale holders
127
Δ whales
+10
Inst. holding value
$2.3B
New positions
43
Closed positions
29
Price momentum (1Q)
-4.6%
Put / Call
7/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2022Q4 | Top 18% | -16.9% | -30.5% |
| 2022Q3 | Top 7% | +24.8% | +3.5% |
| 2020Q4 | Top 14% | -13.6% | -26.1% |
| 2020Q1 | Top 9% | -21.8% | +1.3% |
Options Sentiment
Put holders
7
QoQ: -2
Call holders
8
QoQ: -3
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.79
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+396.7%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)